Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.7 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |